术前用药
碘海索
优势比
医学
药品
药物反应
不利影响
药物不良反应
麻醉
内科学
药理学
肾功能
作者
Gerald Wolf,Mark M. Mishkin,Stéphane G. Roux,E F Halpern,Jens Gottlieb,J Zimmerman,Jacob R. Gillen,Cheryl A. Thellman
标识
DOI:10.1097/00004424-199105000-00003
摘要
Wolf GL, Mishkin MM, Roux SG, et al. Comparison of the rates of adverse drug reactions: ionic contrast agents, ionic agents combined with steroids, and nonionic agents. Invest Radiol 1991;26:404–410. The influence of ionic agents alone, of diatrizoate plus two oral doses of methylprednisolone premedication, and of a nonionic agent (iohexol) upon the frequency and severity of adverse drug reactions (ADRs) was compared in ten hospitals during three separate time periods from 1985 to 1989. Nonionic agents were found to reduce significantly total ADRs; 52 of 8857 patients receiving nonionic agents experienced reactions, versus 263 of 6006 patients for ionics (P < .0001). The frequency of reactions classed as mild (2.9% for ionic agents versus 0.476 for nonionic agents: P < .001), moderate (1.2% versus 0.1%; P < .001), or severe (0.37% versus 0.01%; P < .001), also favored nonionic agents. Steroid premedication provided some protection, but iohexol was significantly better with respect to mild reactions (2.9% versus 0.4%, P < .001), moderate reactions (0.9% versus 0.1%, P < .01), and severe reactions (0.25% versus 0.01%, P < .01). The contrast medium was the greatest risk factor for adverse reaction (odds ratio 7.3), while prior contrast reaction (odds ratio 6.25), and hay fever (odds ratio 2.3) were found to be significant independent risks. We conclude that nonionic agents are safer for intravenous use than ionic agents given alone or with corticosteroid premedication.
科研通智能强力驱动
Strongly Powered by AbleSci AI